DLA Piper advised international fund Kryssen Capital as lead investor in the US$45 million Series A investment in Seven Bridges, a Cambridge-based biomedical data analysis company.

The Series A funding will support Seven Bridges' genomics research for cancer treatments and precision medicine

The Boston-based DLA Piper team representing Kryssen was led by partner Jay Sullivan and included counsel Nicole Daley, and associates Tyler Barnett and Jennifer Gardner.